Literature DB >> 30031767

Interactions Between KIR3DS1 and HLA-F Activate Natural Killer Cells to Control HCV Replication in Cell Culture.

Sebastian Lunemann1, Anja Schöbel2, Janine Kah3, Pia Fittje1, Angelique Hölzemer4, Annika E Langeneckert1, Leonard U Hess1, Tobias Poch3, Gloria Martrus5, Wilfredo F Garcia-Beltran6, Christian Körner1, Annerose E Ziegler1, Laura Richert7, Karl J Oldhafer8, Julian Schulze Zur Wiesch9, Christoph Schramm3, Maura Dandri3, Eva Herker2, Marcus Altfeld10.   

Abstract

Killer-cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer (NK) cells. Binding of KIR3DS1 to its recently discovered ligand, HLA-F, activates NK cells and has been associated with resolution of hepatitis C virus (HCV) infection. We investigated the mechanisms by which KIR3DS1 contributes to the antiviral immune response. Using cell culture systems, mice with humanized livers, and primary liver tissue from HCV-infected individuals, we found that the KIR3DS1 ligand HLA-F is up-regulated on HCV-infected cells, and that interactions between KIR3DS1 and HLA-F contribute to NK cell-mediated control of HCV. Strategies to promote interaction between KIR3DS1 and HLA-F might be developed for treatment of infectious diseases and cancer.
Copyright © 2018 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antiviral Immune Response; Human Leukocyte Antigen; Immunity; Regulation

Mesh:

Substances:

Year:  2018        PMID: 30031767     DOI: 10.1053/j.gastro.2018.07.019

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  18 in total

Review 1.  Conserved and variable natural killer cell receptors: diverse approaches to viral infections.

Authors:  Leidy Y Bastidas-Legarda; Salim I Khakoo
Journal:  Immunology       Date:  2019-01-17       Impact factor: 7.397

Review 2.  The antifibrotic role of natural killer cells in liver fibrosis.

Authors:  Yuan Wei; Wang Bingyu; Yang Lei; Yuan Xingxing
Journal:  Exp Biol Med (Maywood)       Date:  2022-04-27

Review 3.  Animal Models of Hepatitis B Virus Infection-Success, Challenges, and Future Directions.

Authors:  Yongzhen Liu; Stephanie Maya; Alexander Ploss
Journal:  Viruses       Date:  2021-04-28       Impact factor: 5.048

Review 4.  The Emerging Roles of Human Leukocyte Antigen-F in Immune Modulation and Viral Infection.

Authors:  Aifen Lin; Wei-Hua Yan
Journal:  Front Immunol       Date:  2019-05-10       Impact factor: 7.561

5.  Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.

Authors:  Shira Weingarten-Gabbay; Susan Klaeger; Siranush Sarkizova; Leah R Pearlman; Da-Yuan Chen; Kathleen M E Gallagher; Matthew R Bauer; Hannah B Taylor; W Augustine Dunn; Christina Tarr; John Sidney; Suzanna Rachimi; Hasahn L Conway; Katelin Katsis; Yuntong Wang; Del Leistritz-Edwards; Melissa R Durkin; Christopher H Tomkins-Tinch; Yaara Finkel; Aharon Nachshon; Matteo Gentili; Keith D Rivera; Isabel P Carulli; Vipheaviny A Chea; Abishek Chandrashekar; Cansu Cimen Bozkus; Mary Carrington; Nina Bhardwaj; Dan H Barouch; Alessandro Sette; Marcela V Maus; Charles M Rice; Karl R Clauser; Derin B Keskin; Daniel C Pregibon; Nir Hacohen; Steven A Carr; Jennifer G Abelin; Mohsan Saeed; Pardis C Sabeti
Journal:  Cell       Date:  2021-06-03       Impact factor: 66.850

Review 6.  HLA Class I Molecules as Immune Checkpoints for NK Cell Alloreactivity and Anti-Viral Immunity in Kidney Transplantation.

Authors:  Burcu Duygu; Timo I Olieslagers; Mathijs Groeneweg; Christina E M Voorter; Lotte Wieten
Journal:  Front Immunol       Date:  2021-07-06       Impact factor: 7.561

Review 7.  The role of natural killer cells in liver inflammation.

Authors:  A J Highton; I S Schuster; M A Degli-Esposti; M Altfeld
Journal:  Semin Immunopathol       Date:  2021-07-07       Impact factor: 9.623

Review 8.  Humanized Mouse Models for the Study of Infection and Pathogenesis of Human Viruses.

Authors:  Fritz Lai; Qingfeng Chen
Journal:  Viruses       Date:  2018-11-17       Impact factor: 5.048

9.  A novel antibody combination to identify KIR2DS2high natural killer cells in KIR2DL3/L2/S2 heterozygous donors.

Authors:  Matthew D Blunt; Pauline Rettman; Leidy Y Bastidas-Legarda; Rebecca Fulton; Valentina Capizzuto; Mohammed M Naiyer; James A Traherne; Salim I Khakoo
Journal:  HLA       Date:  2019-01       Impact factor: 4.513

10.  Development of a Novel Prognostic Signature Based on Antigen Processing and Presentation in Patients with Breast Cancer.

Authors:  Aoshuang Qi; Mingyi Ju; Yinfeng Liu; Jia Bi; Qian Wei; Miao He; Minjie Wei; Lin Zhao
Journal:  Pathol Oncol Res       Date:  2021-04-01       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.